Word Learning From Parentese in Autistic Children
The University of Texas at Dallas · with National Institute on Deafness and Other Communication Disorders (NIDCD) · NCT06649916
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 1–4 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 100
- US sites recruiting
- 1
- Study start
- October 4, 2024
- Record last updated
- October 23, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The overall objective of this research is to determine whether parentese delivered in the video format (Aim 1) and in live interaction (Aim 2) facilitates novel word learning in autistic children and to investigate if there are factors that influence the effect of parentese on word learning (Aim 3).
Being studied: Parentese Speech; Adult Registered Speech
Conditions: Autism; Autism Spectrum Disorder; Neurodevelopmental Disorders
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- children with or without a diagnosis of ASD between 18 and 59 months
Exclusion Criteria
- hears another language more than 10% of time based on parent report
- has uncorrected visual impairment or hearing impairment
- has developmental disorders or medical conditions other than ASD that affect language or cognition (excepting psychiatric conditions often comorbid with ASD such as ADHD)
Recruiting US locations
University of Texas at Dallas
Richardson, TX 75080
Site contact: Pumpki L. Su, PhD · 973-883-2384 · lei.su@utdallas.edu
Study contacts (from the official record)
- Pumpki L Su, PhD · 972-883-2384 · lei.su@utdallas.edu
- McKenzie Cullinan, MS · mckenzie.cullinan@utdallas.edu
Similar studies in Texas
All healthy volunteers studies in Texas →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of LY4355756 in Healthy Participants
Eli Lilly and Company
- Location
- Dallas, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- San Antonio, TX + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
Eli Lilly and Company
- Location
- San Antonio, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Radiprodil in Participants With Hepatic Impairment
GRIN Therapeutics, Inc.
- Location
- DeSoto, TX + 1 other US site
- Eligibility basics
- Ages 18–75